14% of hepatocellular carcinoma samples had strong ATAD3A expression, whereas percentages of moderate and no ATAD3A expression were 21% and 65%, respectively (Fig. 6e). The gene discussed is ATAD3A; the disease is hepatocellular carcinoma.